Navigation Links
Affitech in Medical Technology

Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies

... OSLO, Norway, April 28 /PRNewswire/ -- affitech AS, the human antibody therapeutics company, annou... libraries. The researchers from Peregrine, affitech and UT Southwestern Medical Center confirmed previ...al Center (Peregrine's academic collaborators) and affitech demonstrated in in vitro studies that immature den...

Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrine's Fully Human Anti-PS Antibody in Prostate Cancer Model

... from UT Southwestern Medical Center in Dallas and affitech A/S reported that similar to bavituximab, the huma...ent and CEO of Peregrine. "Our collaboration with affitech to generate fully human anti-PS antibodies has pro...s developed through Peregrine's collaboration with affitech A/S. The studies were supported in part by a gran...

Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies

...m of scientists from Peregrine Pharmaceuticals and affitech A/S used a fully human anti-PS antibody, PGN635, t...esearchers from UT Southwestern Medical Center and affitech demonstrated the ability of Peregrine's fully huma...e developed through Peregrine's collaboration with affitech A/S. The study by Dr. Huang, et al. was partly sup...

New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models

...VEGF-induced angiogenesis. We look forward to further assessing R84 as a potential anti-angiogenic clinical candidate." Peregrine in association with affitech has filed a patent application for R84 with the United States Patent and Trademark Office to preserve the right to obtain patent protection in the Uni...

Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models

...human antibody R3 used in these studies was developed in collaboration with affitech AS of Norway. These studies were also supported in part by a postdoctoral f...ason B. Fleming, Rolf A. Brekken. UT Southwestern Medical Ctr., Dallas, TX, affitech AS, Oslo, Norway, Peregrine Pharmaceuticals Inc., Tustin, CA, UT-MD Anderso...

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

... OSLO, Norway--(BUSINESS WIRE)--Apr 23, 2007 - affitech AS, the human antibody therapeutics company announ...n therapeutic antibody program " Editors notes affitech AS is a privately held human therapeutic antibody ...rrently in development were generated by CBAS(TM). affitech also sells its proprietary Protein L product line ...
Affitech in Biological News

Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies

...m of scientists from Peregrine Pharmaceuticals and affitech A/S used a fully human anti-PS antibody, PGN635, t...esearchers from UT Southwestern Medical Center and affitech demonstrated the ability of Peregrine's fully huma...e developed through Peregrine's collaboration with affitech A/S. The study by Dr. Huang, et al. was partly sup...
Affitech in Biological Technology

Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company

COPENHAGEN and OSLO, March 4 /PRNewswire/ -- Pharmexa A/S and Affitech AS announced today that they have entered into a conditional agreement to merge the two companies by means of a share for share acquisition by Pharmexa A/S of the private Norwegian company, Affitech AS. The purpose of the m...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

TUSTIN, Calif. and HORSHOLM, Denmark, July 22 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) and Affitech A/S (Nasdaq OMX: AFFI) today announced that they have entered into a licensing agreement for antibody therapeutic rights under Peregrine's ...

Affitech Acquires Pharmexa's Diabody Technology

... OSLO, Norway, October 28 /PRNewswire/ -- affitech AS, the human therapeutic antibody company, today ...ollows an exclusive license of the diabody IP that affitech obtained in 2007 from Pharmexa to carry out certai...s sub-licensing arrangements with third parties. affitech CEO Martin Welschof commented: "This is a key st...

Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration

... OSLO, September 23 /PRNewswire/ -- affitech AS, the Norwegian human antibody therapeutics comp...ant antibodies against an unnamed oncology target. affitech has successfully used its MBAS (Molecule Based Ant...hof, Ph.D., Chief Executive Officer of Affitech. affitech and Roche entered into this collaboration in 2007 ...

Affitech Appoints Dr. Keith McCullagh as Chairman

... OSLO, Norway, September 9 /PRNewswire/ -- affitech AS, the Norwegian antibody therapeutics company, t...biopharmaceuticals market, but I am confident that affitech will benefit from his leadership and guidance. I w...novative potential new products. I look forward to affitech achieving several competitive commercial goals in ...

Affitech and Omeros Enter Into Antibody Discovery and Development Agreement

...ased clinical-stage biopharmaceutical company, and affitech AS, a Norwegian human antibody therapeutics compan... to advance the development of its MASP-2 program. affitech will apply its expansive human antibody libraries ... at Oxford University. Notes to editors: About affitech AS ...
Other Tags
(Date:8/28/2015)... ... August 29, 2015 , ... Rio Salado College joined ... student experience as part of the EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough ... is the third Breakthrough Models Incubator hosted by EDUCAUSE and NGLC, which ...
(Date:8/28/2015)... , ... August 28, 2015 , ... The Kentucky State ... are qualified for the position they are applying for, they are unable to pass ... employers are considering altering drug testing policies in order to be able to hire ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... and Best Practices for Compliance, **Presented by FDAnews and GessNet**, Oct. 14-15, ... internationally renowned expert Fubin Wu, has been specifically designed to provide devicemakers ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... or those who might personally be struggling with chemical dependency, may be able ... Best Drug Rehabilitation, a results-driven holistic treatment center for addiction located in Western ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... nationwide. Addictions specialist, Dr. James Strawbridge, gives a new approach on solutions in ... should begin with the employer and employees getting together for meaningful group meetings. ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015 /PRNewswire/ ... announced today it will unveil its "Guardian S" snake ... the National Tactical Officers Association Conference on August 30 ... S is the first-ever commercially available energetically autonomous snake ... and in-field trials and is protected by more than ...
(Date:8/20/2015)... OXFORD, CT ., Aug. 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... wallet, announces it has joined The Smart Card Alliance ... the Smart Card Alliance and the Smart Card Alliance ... and visibility to industry peers and thought leaders promoting ...
(Date:8/12/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is proud to announce that iMedNet ... platform, has led the way to significant and unprecedented ...   Q2 2015 and Q1 2015 were, respectively, the ... sold in the company,s 15 year history.  In addition, ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
Other Contents